„First Line“
Suchergebnisse
3.416 Treffer
-
Prognostic Impact of Early Treatment Interruption of Nivolumab Plus Ipilimumab Due to Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Multi-Institution Retrospective Study
-
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy
-
Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations
-
Retrospective study of thoracic endovascular aortic repair as a first-line treatment for traumatic blunt thoracic aortic injury
-
Variational Analysis Perspective on Linear Convergence of Some First Order Methods for Nonsmooth Convex Optimization Problems
-
Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas
-
Müller–Zhang truncation for general linear constraints with first or second order potential
-
Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK
-
DTG-based first-line therapy appears to be cost effective in Ethiopia
-
Diuretics are most cost effective first-line antihypertensives in Croatia
-
Onset PrevenTIon of urinary retention in Orthopaedic Nursing and rehabilitation, OPTION—a study protocol for a randomised trial by a multi-professional facilitator team and their first-line managers’ implementation strategy
-
Alignment between the patient’s cancer worry and the GP’s cancer suspicion and the association with the interval between first symptom presentation and referral: a cross-sectional study in Denmark
-
Atezolizumab als First-Line-Monotherapie bei hoher PD-L1-Expression
-
NSCLC: Atezolizumab als First-Line-Monotherapie bei hoher PD-L1-Expression
-
Hepatic Artery Infusion Pump (HAIP) Therapy Versus Chemotherapy in the First-Line Setting for Patients with Unresectable Intrahepatic Cholangiocarcinoma
-
Nivolumab + ipilimumab + chemotherapy not cost effective as first-line therapy for NSCLC
-
Dacomitinib not cost effective for first-line therapy of advanced NSCLC
-
Effects of oral colchicine administration as first-line adjunct therapy in myopericarditis
-
First passage times for Slepian process with linear and piecewise linear barriers
-
First Report of Oncological Outcome and Prognostic Analysis in a First-Line Setting of Short Hydration Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Urothelial Carcinoma